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1. INTRODUCTION 
Clofibrate and other hypolipidemic drugs in- 
crease the number of hepatic peroxisomes and 
cause a corresponding increase of several peroxi- 
somal enzyme activities [ 1,2]. This effect regards 
HlOz-generating reactions (most typically, palmi- 
toyl-CoA oxidase activity) and catalase, which is 
able to destroy most of the Hz02 formed within the 
organelle. It is reasonable to expect that the net flux 
of Hz02 outside the organelle should be enhanced 
under hypolipidemic treatment in view of the fact 
that significant Hz02 diffusion is observed in per- 
oxisomes of untreated animals [3,4] and the increase 
of palmitoyl-CoA oxidase activity induced by clo- 
tibrate feeding is much higher than that of catalase 
[ 11. Moreover, hypolipidemic agents cause prolif- 
eration of hepatic smooth endoplasmic reticulum as 
well, and this produces a marked increase of cyto- 
chrome P450 [5], which is likely to be a major source 
of Ozand H202 in the cell as suggested by results 
obtained with subcellular preparations [6,7]. It 
seemed therefore interesting to investigate whether 
activities of cytoplasmic enzymes acting as a defense 
against ‘oxygen radicals’ (i.e., superoxide dis- 
mutase and glutathione peroxidase) are affected by 
feeding hypolipidemic drugs. The results reported 
here show that both enzymes are significantly de- 
creased in rat liver during treatment with clofibrate 
and procetofene, another hypolipidemic agent [S]. 
This effect is associated with an increased suscepti- 
bility of the tissue to enhanced peroxidative risk, as 
* To whom correspondence should be addressed 
detected by malonyl dialdehyde formation under 
conditions known to give rise to peroxidizing ‘oxy- 
gen radicals’ [9]. 
2. MATERIALS AND METHODS 
2.1. Materials 
Purest grade chemicals were used: t-butyl- 
hydroperoxide was obtained from Merck- 
Schuchardt; GSH, GSSG reductase, NADPH, and 
purest grade catalase ( -65 000 U/mg) were pur- 
chased from Boehringer; bovine serum albumin 
(BSA)wasobtainedfromSigmaChemicalCo.;super- 
oxide dismutase (SOD) was purified from bovine 
erythrocytes as in [lo]; ADP and 1,1,3,3-tetra- 
ethoxypropane (TEP) from Fluka, ethyl a-@- 
chlorophenoxy)isobutyrate (clofibrate) and iso- 
propyl-cY-(4-p-chlorobenzoyl phenoxy)iso-butyrate 
(procetofene) were obtained from CFM, Milan. 
2.2. Animals and treatment 
Male (140-160g) and female (120-140 g) Wistar 
rats were treated for 30 days with daily per OS doses 
of 300 mg clofibrate/kg and 100 mg procetofenej 
kg. Such doses are currently used for animal 
experimentation with hypolipidemic drugs [8,11]. 
After killing, livers were exhaustively perfused with 
saline to remove blood, and then homogenized ( 1:6, 
w/v) with 5 mM phosphate buffer (pH 7.4) contain- 
ing 0.2 mM EDTA. Before assaying for the 
enzyme activities, homogenates were sonicated for 
5 min, in 30 s bursts, in ice bath. The microsomal 
and cytosolic fractions were prepared as in [ 121. 
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2.3. Assay methods 
Protein was determined as in [ 131 with bovine 
serum albumin as astandard. SOD was determined 
by a polarographic method [ 141 and its activity was 
expressed as pg enzyme/mg protein, with reference 
to a sample of purified bovine enzyme. Glutathione 
peroxidase (GSH-Px) activity was assayed with a 
spectrophotometric method using t-butyl-hydroper- 
oxide as substrate [ 151. Aspartate aminotransferase 
(AAT) activity was measured as in [16]. Both these 
enzyme activities are expressed as units (M sub- 
strate transformed . mint . mg protein-‘). Al- 
dehyde oxidase activity was assayed with pyrid- 
oxal as substrate by measuring at alkaline pH the 
fluorescence of the product pyridoxic acid in its 
lactone form [ 171; the activity is expressed as fluor- 
escence intensity (F)/mg protein. Catalase and 
urate oxidase activities were measured by UV 
methods and expressed in the units [ 18,191. 
Susceptibility to lipid peroxidation was detected 
d A---- -----8 
25 _ 
9 
by malonyl dialdehyde (MDA) formation after oxi- 
dative challenge of liver homogenates or micro- 
somal fractions with ADP-Fe3+ in the presence of 
NADPH [9]. MDA was measured by a calorimetric 
procedure involving reaction with thiobarbituric 
acid 1201; the results are expressed as nmol . 
MDA -’ . mg protein -’ using TEP as an external 
standard. 
3. RESULTS 
Table 1 shows the effects of clotibrate and proce- 
tofene on several enzyme activities of rat liver. The 
increase of catalase, which is known to be much 
higher in male animals [21], has to be confronted 
with the unaltered values of AAT and urate oxidase 
and the significant lower activities of GSH-Px and 
SOD. In the case of procetofene the decrease of the 
2 latter enzyme activities is much more evident in 
male than in female animals. Table 1 also reports 


















Fig. 1. MDA production by liver homogenates of rats fed with procetofene upon treatment with ADP-Fe3+ in the presence 
of NADPH. Total liver protein (70 mg) was incubated for 2 h at 37°C in the presence of 4 mM ADP and 0.012 mM FeCls 
with 0.4 mM NADPH as substrate, in 5 mM phosphate buffer (pH 7.4). The figure shows MDA production in the absence 
(o) and in the presence (0) of NADPH and ADP-Fe 3 + by liver homogenates of male (d) and female (0) control (A) and 
procetofene-fed (B) rats. The activity of aldehyde oxidase (A) of the same liver homogenates is also shown. The data 
pertaining to the same sample are connected by dotted (ald.ox. vs basal MDA) and solid (basal vs induced MDA) lines. 
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Table 1 
Enzyme activities in liver homogenates of rats fed with clotibrate or procetofene 
August 1982 
Sex 
SOD p GSH-Px p GSH-Px AAT Catalase Urate oxidase 
(pg/mg (U/mg SOD (U/mg 
protein) protein X 104) 
(U/mg (U/mg 
Treatment protein X 104) protein) protein) 
Male Control 2.53 20.32 2.53 + 0.20 1.0 2.8O-cO.10 10.87+ 1.03 2.67kO.19 
Clofibrate 1.98 20.25 <<O.OOl 2.002 0.08 <O.OOl 1.0 2.85 r 0.25 26.912 1.34 2.9620.17 
Procetofene 1.85 k0.24 <<O.OOl 2.0420.26 <O.OOl 1.1 2.90-c 0.5 1 25.6OkO.64 2.8OkO.21 
Female Control 2.71 k0.35 4.69 + 0.50 1.7 2.OOr0.10 8.602 1.75 3.0820.25 
Clotibrate 1.96 + 0.29 <O.Ol 2.85 + 0.03 <O.OOl 1.5 2.1520.14 12.21+ 1.56 3.2lkO.21 
Procetofene 2.38 + 0.18 <0.05 3.5620.38 <O.OOl 1.5 2.29kO.17 12.28+ 1.25 2.93-cO.41 
Data are expressed as mean values ‘_ SD. Statistical evaluation were performed by Student’s l-test: p < 0.05 = 
significant. Each group consists of 10 animals. Catalase values were the same after homogenization in the presence of 
Triton X-100 and treatment of the homogenate with ethanol to destroy any inactive complex II [26]. 
the values of the ratio between the GSH-Px and the 
SOD activities under the different conditions. This 
value is higher in female rats independently of 
treatment, the GSH-Px activity being sex-depen- 
dent. No effects of the drugs on GSH-Px and SOD 
activities were observed upon addition of 5 mM 
drug to the assay system, even after 7 h incubation 
at room temperature. 
Fig.1 reports the results of MDA determinations 
in liver homogenates after incubation with 
ADP-Fe3+ in the presence of NADPH. MDA was 
found to form over the endogenous level only in 
treated male rats. Aldehyde oxidase activity, which 
could affect the level of aldehyde actually detected, 
was also determined in all samples. The variations 
measured were found to be very large and not re- 
lated to MDA values. Therefore they are not to be 
considered causative of the amount of MDA 
formed. 
The ADP-Fe3+-dependent lipid peroxidation is 
usually studied with isolated microsomal fractions 
[9]. Therefore, the data in fig.1 cannot be used for 
any valid interpretation of the mechanism by which 
ADP-Fe3+ induces increased MDA production in 
male rats only. Isolated subcellular fractions were 
used to test the hypothesis that MDA production in 
these conditions can actually be related to anti- 
oxidant enzyme systems. 
266 
Table 2 
ADP-Fe3+-dependent MDA production by rat liver 
microsomes [9] under various conditions 
Incubation mixture MDA increase 
(W) 
1. Microsomes (2.5 mg protein/ml 
2. Microsomes + cytosolic fraction (8 mg 
protein/ml containing 0.6 x 10 -6 M 
SOD, 25 x 10e4 U GSH-Px/ml and 20 
U catalase/ml) 
3. Microsomes + heat-treated cytosolic 
fraction (10 min in boiling water 
bath); 
residual enzyme activities: 0.02 x 10 -6 
M SOD; 0.26 x 10e4 U GSH-Px/ml; 
catalase, not detectable 
4. Microsomes + BSA (8 mg/ml) 
5. Microsomes + 500 U catalase/ml 
6. Microsomes + 2x lO-6 M SOD 









a The total cell homogenate contains 3 X lo- 6 M SOD, 
88 x lo- 4 U GSH-Px/ml and 400 U catalase/ ml 
The results are expressed as % induced MDA, with res- 
pect to the endogenous level (i.e., in the absence of 
ADP-Fe3+) 
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Table 2 reports a series of experiments carried out 
to this aim. The results show that catalase at a con- 
centration comparable to that of the total homo- 
genate inhibits ADP-Fe3+-dependent MDA pro- 
duction, while superoxide dismutase alone does not 
and even produces an increase of MDA produc- 
tion over the control value. However a mixture of 
SOD and catalase seems to have a higher inhibitory 
effect than catalase alone. Addition to microsomes 
of a cytosolic extract naturally equipped with SOD 
and GSH-Px and practically devoid of catalase had 
an inhibitory effect as well. Partial inactivation of 
SOD and GSH-Px by heat treatment of the cytoso- 
lit extract led to a roughly proportional loss of in- 
hibition. The specificity of the effect of the cytosolic 
extract was supported by the lack of any inhibitory 
effect by BSA at a comparable protein concentra- 
tion. 
should reasonably produce a better control of the 
H202 flux in the cytoplasm. 
4. DISCUSSION 
The decrease of GSH-Px and SOD activities in 
liver of rats treated with 2 hypolipidemic drugs is 
significant, not imputable to indiscriminate effects 
on cytoplasmic enzymes (AAT is not changed) and 
neither related to interference of the drugs with the 
assay system nor to inhibition of the enzyme activi- 
ty. Such a repression of cytoplasmic enzymes is 
rather unexpected, as the effects of hypolipidemic 
drugs in [ 1,5] were restricted to membrane enzymes 
and associated with membrane proliferation. The 
nature of such a repression is obscure, however its 
clear sex-dependence (see table l), analogous to 
that shown for peroxisomal enzymes 1211, points to 
complex mechanisms, perhaps involving biosyn- 
thesis of the enzymes. 
The relevance of the reported observations is 
2-fold: 
(i) They may offer an additional tool for studying 
the regulation of the cellular content of such 
important enzymes as those acting on active 
oxygen derivatives in the cytoplasm, i.e., SOD 
and GSH-Px; 
In fact, SOD increases the rate of Hz02 produc- 
tion through 0~ dismutation, and such an effect 
would result in harmful consequences if its activity 
is not balanced by proper amounts of GSH-Px. 
Hz02 is the most sable among partially reduced 
oxygen derivatives and is directly involved in all the 
molecular mechanisms of oxidative damage (per- 
oxidation, Fenton reaction, Haber-Weiss reaction, 
etc.; see [23-251. The results shown in fig.1 and 
table 2 are in line with this hypothesis. Under con- 
ditions of increased production of oxygen radicals 
from 0% as those set by incubation of the tissue with 
NADPH and GDP-Fe3+ [9], more MDA, an estab- 
lished marker of enhanced lipid preoxidation, is 
formed in liver of treated male rats only. Livers of 
female rats, which seem to be insensitive in this 
regard, have a much higher GSH-Px content, and 
maintain rather high values of GSH-Px activity and 
GSH-Px/SOD ratio after treatment in spite of the 
decrease induced by the 2 hypolipidemic drugs. The 
relevance of protection against Hz02 present in to- 
tal cell homogenate from ADP-Fe3+ is supported 
by the highly protective effect of catalase (table 2) 
added to a microsomal preparation, in contrast to 
the lack of any effect by SOD. The mixture of SOD 
and catalase inhibits more than catalase alone. 
These results confirm the above proposal: SOD 
itself would lead to an increased flux of peroxid- 
izing H202 in the cell, however its concerted action 
with HzOz-removing enzymes improves the anti- 
oxidant capability of cells (perhaps YS OH.; see 
[23-251. A further indication that the interpretation 
of the results of fig. 1 is a valid one comes from the 
experiment where a cytosolic fraction was added to 
microsomes. The cytosolic extract showed specific 
protection (BSA, in fact, was ineffective) due to the 
presence of heat-labile enzymic factors. This pro- 
tection is very likely to be due to the natural com- 
bination of GSH-Px and SOD activity: partial heat 
inactivation of the 2 enzymes is actually paralleled 
by loss of inhibition of MDA production. 
(ii) They reinforce the idea that these 2 enzymes, 
and in particular GSH-Px, are key factors in the 
cell defense against deleterious effects of oxy- 
gen radicals. REFERENCES 
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